BrainZell uses stem cell-based models that match the human brain better than that of animals.
BrainZell has raised $1.5M in total funding. The most recent round was Seed. The last funding was announced in June 2024.
BrainZell's investors include Creator Fund, Sting, Norrsken Evolve.
BrainZell is headquartered in Stockholm, Sweden.
BrainZell uses stem cell-based models that match the human brain better than that of animals.
BrainZell is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BrainZell — Funding & Investors." VCBacked, June 3, 2024, https://www.vcbacked.co/company/brainzell. Accessed September 30, 2026.
VCBacked. (2024). BrainZell — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/brainzell
{{cite web |title=BrainZell — Funding & Investors |url=https://www.vcbacked.co/company/brainzell |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated